These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29950315)

  • 1. Disrupting LXRα phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation.
    Gage MC; Bécares N; Louie R; Waddington KE; Zhang Y; Tittanegro TH; Rodríguez-Lorenzo S; Jathanna A; Pourcet B; Pello OM; De la Rosa JV; Castrillo A; Pineda-Torra I
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6556-E6565. PubMed ID: 29950315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage Lxrα reduces atherosclerosis in Ldlr
    Yin Y; Zeng S; Li Y; Wu Z; Huang D; Gao P
    Biochem Biophys Res Commun; 2020 Aug; 529(3):540-547. PubMed ID: 32736671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting LXRα phosphorylation in hematopoietic cells reduces inflammation and attenuates atherosclerosis and obesity in mice.
    Voisin M; Shrestha E; Rollet C; Nikain CA; Josefs T; Mahé M; Barrett TJ; Chang HR; Ruoff R; Schneider JA; Garabedian ML; Zoumadakis C; Yun C; Badwan B; Brown EJ; Mar AC; Schneider RJ; Goldberg IJ; Pineda-Torra I; Fisher EA; Garabedian MJ
    Commun Biol; 2021 Mar; 4(1):420. PubMed ID: 33772096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired LXRα Phosphorylation Attenuates Progression of Fatty Liver Disease.
    Becares N; Gage MC; Voisin M; Shrestha E; Martin-Gutierrez L; Liang N; Louie R; Pourcet B; Pello OM; Luong TV; Goñi S; Pichardo-Almarza C; Røberg-Larsen H; Diaz-Zuccarini V; Steffensen KR; O'Brien A; Garabedian MJ; Rombouts K; Treuter E; Pineda-Torra I
    Cell Rep; 2019 Jan; 26(4):984-995.e6. PubMed ID: 30673619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
    Doran AC; Ozcan L; Cai B; Zheng Z; Fredman G; Rymond CC; Dorweiler B; Sluimer JC; Hsieh J; Kuriakose G; Tall AR; Tabas I
    J Clin Invest; 2017 Nov; 127(11):4075-4089. PubMed ID: 28972541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages.
    Vinod M; Chennamsetty I; Colin S; Belloy L; De Paoli F; Schaider H; Graier WF; Frank S; Kratky D; Staels B; Chinetti-Gbaguidi G; Kostner GM
    Biochim Biophys Acta; 2014 Jun; 1841(6):827-35. PubMed ID: 24603323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.
    Zhou X; He W; Huang Z; Gotto AM; Hajjar DP; Han J
    J Biol Chem; 2008 Jan; 283(4):2129-38. PubMed ID: 18029360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LXRα regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8.
    Pourcet B; Feig JE; Vengrenyuk Y; Hobbs AJ; Kepka-Lenhart D; Garabedian MJ; Morris SM; Fisher EA; Pineda-Torra I
    Circ Res; 2011 Aug; 109(5):492-501. PubMed ID: 21757649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
    Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Macrophage Gene Expression via Liver X Receptor α Serine 198 Phosphorylation.
    Wu C; Hussein MA; Shrestha E; Leone S; Aiyegbo MS; Lambert WM; Pourcet B; Cardozo T; Gustafson JA; Fisher EA; Pineda-Torra I; Garabedian MJ
    Mol Cell Biol; 2015 Jun; 35(11):2024-34. PubMed ID: 25825525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid LXR (Liver X Receptor) Deficiency Induces Inflammatory Gene Expression in Foamy Macrophages and Accelerates Atherosclerosis.
    Endo-Umeda K; Kim E; Thomas DG; Liu W; Dou H; Yalcinkaya M; Abramowicz S; Xiao T; Antonson P; Gustafsson JÅ; Makishima M; Reilly MP; Wang N; Tall AR
    Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):719-731. PubMed ID: 35477277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis.
    Sallam T; Ito A; Rong X; Kim J; van Stijn C; Chamberlain BT; Jung ME; Chao LC; Jones M; Gilliland T; Wu X; Su GL; Tangirala RK; Tontonoz P; Hong C
    J Lipid Res; 2014 Jun; 55(6):1120-30. PubMed ID: 24671012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage LXRα gene therapy ameliorates atherosclerosis as well as hypertriglyceridemia in LDLR(-/-) mice.
    Li G; Biju KC; Xu X; Zhou Q; Chen C; Valente AJ; He W; Reddick RL; Freeman GL; Ahuja SS; Clark RA; Li S
    Gene Ther; 2011 Aug; 18(8):835-41. PubMed ID: 21390069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine-1-Phosphate Receptor 1, Expressed in Myeloid Cells, Slows Diet-Induced Atherosclerosis and Protects against Macrophage Apoptosis in Ldlr KO Mice.
    Gonzalez L; Qian AS; Tahir U; Yu P; Trigatti BL
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic Reticulum Stress Affects Cholesterol Homeostasis by Inhibiting LXRα Expression in Hepatocytes and Macrophages.
    Wang T; Zhao Y; You Z; Li X; Xiong M; Li H; Yan N
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33050595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of LXRα prevents arsenic-enhanced atherosclerosis, but not arsenic-altered plaque composition.
    Lemaire M; Lemarié CA; Flores Molina M; Guilbert C; Lehoux S; Mann KK
    Toxicol Sci; 2014 Dec; 142(2):477-88. PubMed ID: 25273567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.
    Bradley MN; Hong C; Chen M; Joseph SB; Wilpitz DC; Wang X; Lusis AJ; Collins A; Hseuh WA; Collins JL; Tangirala RK; Tontonoz P
    J Clin Invest; 2007 Aug; 117(8):2337-46. PubMed ID: 17657314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis.
    Schneider JG; Yang Z; Chakravarthy MV; Lodhi IJ; Wei X; Turk J; Semenkovich CF
    J Biol Chem; 2010 Jul; 285(30):23398-409. PubMed ID: 20479009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice.
    Bischoff ED; Daige CL; Petrowski M; Dedman H; Pattison J; Juliano J; Li AC; Schulman IG
    J Lipid Res; 2010 May; 51(5):900-6. PubMed ID: 20388921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.